124 related articles for article (PubMed ID: 2611626)
1. Chemotherapy of advanced seminoma: clinical significance of radiological findings before and after treatment.
Fosså SD; Kullmann G; Lien HH; Stenwig AE; Ous S
Br J Urol; 1989 Nov; 64(5):530-4. PubMed ID: 2611626
[TBL] [Abstract][Full Text] [Related]
2. Gallium scans in the evaluation of residual masses after chemotherapy for seminoma.
Warren GP; Einhorn LH
J Clin Oncol; 1995 Nov; 13(11):2784-8. PubMed ID: 7595739
[TBL] [Abstract][Full Text] [Related]
3. Treatment of the residual retroperitoneal mass after chemotherapy for advanced seminoma.
Ellison MF; Mostofi FK; Flanigan RC
J Urol; 1988 Sep; 140(3):618-20. PubMed ID: 3411688
[TBL] [Abstract][Full Text] [Related]
4. Management of postchemotherapy residual mass in patients with advanced seminoma: Indiana University experience.
Schultz SM; Einhorn LH; Conces DJ; Williams SD; Loehrer PJ
J Clin Oncol; 1989 Oct; 7(10):1497-503. PubMed ID: 2778480
[TBL] [Abstract][Full Text] [Related]
5. Positron emission tomography scans in the evaluation of postchemotherapy residual masses in patients with seminoma.
Ganjoo KN; Chan RJ; Sharma M; Einhorn LH
J Clin Oncol; 1999 Nov; 17(11):3457-60. PubMed ID: 10550142
[TBL] [Abstract][Full Text] [Related]
6. Residual mass: an indication for further therapy in patients with advanced seminoma following systemic chemotherapy.
Motzer R; Bosl G; Heelan R; Fair W; Whitmore W; Sogani P; Herr H; Morse M
J Clin Oncol; 1987 Jul; 5(7):1064-70. PubMed ID: 3598610
[TBL] [Abstract][Full Text] [Related]
7. VAB-6 as initial treatment of patients with advanced seminoma.
Stanton GF; Bosl GJ; Whitmore WF; Herr H; Sogani P; Morse M; Golbey RB
J Clin Oncol; 1985 Mar; 3(3):336-9. PubMed ID: 2579214
[TBL] [Abstract][Full Text] [Related]
8. Extragonadal seminoma: an international multicenter analysis of prognostic factors and long term treatment outcome.
Bokemeyer C; Droz JP; Horwich A; Gerl A; Fossa SD; Beyer J; Pont J; Schmoll HJ; Kanz L; Einhorn L; Nichols CR; Hartmann JT
Cancer; 2001 Apr; 91(7):1394-401. PubMed ID: 11283942
[TBL] [Abstract][Full Text] [Related]
9. Advanced seminoma: the role of chemotherapy and adjunctive surgery.
Motzer RJ; Bosl GJ; Geller NL; Penenberg D; Yagoda A; Golbey R; Whitmore WF; Fair WR; Sogani P; Herr H
Ann Intern Med; 1988 Apr; 108(4):513-8. PubMed ID: 2450500
[TBL] [Abstract][Full Text] [Related]
10. Management of testicular seminoma advanced disease. Report on 14 cases and review of the literature.
Porcaro AB; Antoniolli SZ; Maffei N; Beltrami P; Bassetto MA; Curti P
Arch Ital Urol Androl; 2002 Jun; 74(2):81-5. PubMed ID: 12161942
[TBL] [Abstract][Full Text] [Related]
11. Platinum-based chemotherapy of primary extragonadal germ cell tumours: the Hellenic Cooperative Oncology Group experience.
Pectasides D; Aravantinos G; Visvikis A; Bakoyiannis C; Halikia A; Kalofonos C; Kosmidis P; Skarlos D; Fountzilas G
Oncology; 1999 Jul; 57(1):1-9. PubMed ID: 10394118
[TBL] [Abstract][Full Text] [Related]
12. Nonseminomatous germ cell tumors: enlarging masses despite chemotherapy.
Panicek DM; Toner GC; Heelan RT; Bosl GJ
Radiology; 1990 May; 175(2):499-502. PubMed ID: 2158120
[TBL] [Abstract][Full Text] [Related]
13. [Successful chemotherapy in undescended testicular and extragonadal germ cell tumors: report of 2 cases].
Imamura T; Unoki T; Tamura K; Seita M; Shibata K
Gan To Kagaku Ryoho; 1986 Aug; 13(8):2658-62. PubMed ID: 2427033
[TBL] [Abstract][Full Text] [Related]
14. Primary malignant mediastinal germ cell tumours: improved prognosis with platinum-based chemotherapy and surgery.
Childs WJ; Goldstraw P; Nicholls JE; Dearnaley DP; Horwich A
Br J Cancer; 1993 May; 67(5):1098-101. PubMed ID: 8494705
[TBL] [Abstract][Full Text] [Related]
15. Adjunctive surgery after chemotherapy for nonseminomatous germ cell tumors: recommendations for patient selection.
Toner GC; Panicek DM; Heelan RT; Geller NL; Lin SY; Bajorin D; Motzer RJ; Scher HI; Herr HW; Morse MJ
J Clin Oncol; 1990 Oct; 8(10):1683-94. PubMed ID: 2170590
[TBL] [Abstract][Full Text] [Related]
16. False positive 2-(18)Fluroro-deoxy-D-glucose positron emission tomography (FDG-PET) in patients with disseminated seminoma and post-chemotherapy residual masses.
Wagner M; Bellmunt J; Boutros C; Bonardel G; Loriot Y; Albiges L; Massard C; Fizazi K
Clin Genitourin Cancer; 2013 Mar; 11(1):66-9. PubMed ID: 22981209
[No Abstract] [Full Text] [Related]
17. Comparison of histological results from the resection of residual masses at different sites after chemotherapy for metastatic non-seminomatous germ cell tumours.
Hartmann JT; Candelaria M; Kuczyk MA; Schmoll HJ; Bokemeyer C
Eur J Cancer; 1997 May; 33(6):843-7. PubMed ID: 9291803
[TBL] [Abstract][Full Text] [Related]
18. Retroperitoneal lymphadenectomy for post-chemotherapy residual masses: is a modified dissection and resection of residual masses sufficient?
Rabbani F; Goldenberg SL; Gleave ME; Paterson RF; Murray N; Sullivan LD
Br J Urol; 1998 Feb; 81(2):295-300. PubMed ID: 9488075
[TBL] [Abstract][Full Text] [Related]
19. The treatment of extragonadal seminoma.
Jain KK; Bosl GJ; Bains MS; Whitmore WF; Golbey RB
J Clin Oncol; 1984 Jul; 2(7):820-7. PubMed ID: 6204019
[TBL] [Abstract][Full Text] [Related]
20. [Intra-arterial chemotherapy with cis-diamminedichloroplatinum (CDDP) for primary mediastinal seminoma].
Kuritsuka H; Narahara R; Sigeta M; Kobayashi Y; Kondo M; Fujita M; Ohno K; Kushima K
Nihon Gan Chiryo Gakkai Shi; 1990 Nov; 25(11):2711-6. PubMed ID: 2277222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
